Nature Made — Cyborg Score 7/10

Strong
Dietary Supplements & Vitamins

Strategic Profile

Nature Made earned the most No. 1 rankings by U.S. News & World Report, topping the lists of 12 categories and reinforcing its position as the #1 Pharmacist Recommended vitamin and supplement brand (June 2026). In March 2026, Nature Made continued expansion of its Gut Health offerings with the launch of SuperGreens and Digestive Enzymes, positioning it at the forefront of consumer wellness trends while leveraging its parent company's manufacturing and distribution scale.

Cyborg Score Rationale

Nature Made maintains dominant market positioning as the #1 pharmacist-recommended vitamin brand with strong third-party validation (U.S. News rankings, June 2026). However, as a private subsidiary of a larger Japanese pharmaceutical conglomerate, growth visibility is limited. Recent product expansions into high-growth segments like gut health demonstrate strategic execution.

Top Insights

  • Ranked #1 Vitamin Brand by U.S. News & World Report in June 2026 across 14 categories with most No. 1 products than any competitor
  • Actively expanding into adjacent wellness categories: gut health (SuperGreens, Digestive Enzymes launched March 2026) and women's health via parent Pharmavite's acquisitions
  • Parent company Pharmavite operates multi-brand portfolio (Nature Made, MegaFood, Bonafide, Uqora) generating scale and cross-selling opportunities
  • Owned by Otsuka Pharmaceutical since 1989, providing capital access and global distribution but limiting independence

Named Competitors

  • Nature's Bounty — Broadline vitamin and supplement brand
  • SmartyPants — Gummy vitamin and supplement brand
  • Havasu Nutrition — Nutritional supplement brand
  • NOW Foods — Health products across dietary supplements, natural foods, and sports nutrition

Recent Developments

  • (June 2026) Named #1 Vitamin Brand by U.S. News & World Report with 12 category No. 1 rankings
  • (March 2026) Launched SuperGreens and Digestive Enzymes to expand gut health product line
  • (November 2023) Parent company Pharmavite acquired Bonafide Health (menopause solutions) for $425 million

Open the full interactive Nature Made report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →